920 related articles for article (PubMed ID: 25339479)
21. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
[TBL] [Abstract][Full Text] [Related]
23. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
[TBL] [Abstract][Full Text] [Related]
24. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
25. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.
Sahin FK; Sahin SB; Ural UM; Cure MC; Senturk S; Tekin YB; Balik G; Cure E; Yuce S; Kirbas A
Bosn J Basic Med Sci; 2015 Jul; 15(3):57-63. PubMed ID: 26295295
[TBL] [Abstract][Full Text] [Related]
26. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.
Liu RB; Liu Y; Lv LQ; Xiao W; Gong C; Yue JX
Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998
[TBL] [Abstract][Full Text] [Related]
27. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
28. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study.
Temur M; Calan M; Akşit M; Yılmaz Ö; Çift T; Akselim B; Dinçgez Çakmak B; Üstünyurt E
Ginekol Pol; 2017; 88(10):517-522. PubMed ID: 29192411
[TBL] [Abstract][Full Text] [Related]
29. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
30. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
31. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
[TBL] [Abstract][Full Text] [Related]
32. Serum HLA-G levels in women with polycystic ovary syndrome.
Oztekin O; Fenkci SM; Fenkci V; Enli Y; Cabus U
Gynecol Endocrinol; 2015 Mar; 31(3):243-6. PubMed ID: 25403326
[TBL] [Abstract][Full Text] [Related]
33. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
34. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls.
Huddleston HG; Quinn MM; Kao CN; Lenhart N; Rosen MP; Cedars MI
Clin Endocrinol (Oxf); 2017 Dec; 87(6):775-782. PubMed ID: 29044581
[TBL] [Abstract][Full Text] [Related]
35. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
36. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
[TBL] [Abstract][Full Text] [Related]
37. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
38. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Yavuz DG
J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
[TBL] [Abstract][Full Text] [Related]
39. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
